Literature DB >> 34314447

Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh.

Md Ashrafur Rahman1, Yeasna Shanjana2, Md Ismail Tushar1, Tarif Mahmud1, Ghazi Muhammad Sayedur Rahman1, Zahid Hossain Milan1, Tamanna Sultana1, Ali Mohammed Lutful Hoq Chowdhury3, Mohiuddin Ahmed Bhuiyan4, Md Rabiul Islam4, Hasan Mahmud Reza1.   

Abstract

BACKGROUND: The hematological abnormalities are assumed to be involved in the disease progression of COVID-19. However, the actual associations between specific blood parameters and COVID-19 are not well understood. Here we aimed to assess the correlations between hematological parameters and the severity of COVID-19.
METHODS: We included COVID-19 patients who were admitted to Evercare Hospital Ltd, Dhaka, Bangladesh, between November 10, 2020, to April 12, 2021, with a confirmed case of RT-PCR test. We recorded demographic information, clinical data, and routine hematological examination results of all COVID-19 patients. We performed statistical analyses and interpretation of data to compare severe COVID-19 patients (SCP) and non-severe COVID-19 patients (NSCP).
RESULTS: The age and BMI of the admitted COVID-19 patients were 48.79±8.53 years and 25.82±3.75 kg/m2. This study included a total of 306 hospitalized COVID-19 patients. Among them, NSCP and SCP were 198 and 108, respectively. And we recorded 12 deaths from SCP. We observed the alterations of several hematological parameters between SCP and NSCP. Among them, we noticed the increased levels of C-reactive protein (CRP), d-dimer, and ferritin showed good indicative value to evaluate the severity of COVID-19. Also, there were positive correlations among these parameters. Moreover, we found correlations between the outcomes of COVID-19 patients with patient's demographics and comorbid diseases.
CONCLUSION: Based on our results, CRP, d-dimer, and ferritin levels at admission to hospitals represent simple assessment factors for COVID-19 severity and the treatment decisions at the hospital setup. These blood parameters could serve as indicators for the prognosis and severity of COVID-19. Therefore, our study findings might help to develop a treatment protocol for COVID-19 patients at the hospital setup.

Entities:  

Year:  2021        PMID: 34314447     DOI: 10.1371/journal.pone.0255379

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  19 in total

1.  Influence of Co-morbidities During SARS-CoV-2 Infection in an Indian Population.

Authors:  Adrian Matysek; Aneta Studnicka; Wade Menpes Smith; Michał Hutny; Paweł Gajewski; Krzysztof J Filipiak; Jorming Goh; Guang Yang
Journal:  Front Med (Lausanne)       Date:  2022-08-01

2.  Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients.

Authors:  Eman T Ali; Azza Sajid Jabbar; Hadeel S Al Ali; Saad Shaheen Hamadi; Majid S Jabir; Salim Albukhaty
Journal:  Int J Inflam       Date:  2022-04-21

Review 3.  Potential role of biochemical markers in the prognosis of COVID-19 patients.

Authors:  Apeksha Niraula; Nirmal Baral; Madhab Lamsal; Mahima Bataju; Saroj Thapa
Journal:  SAGE Open Med       Date:  2022-07-05

4.  Practical Risk Scoring System for Predicting Severity of COVID-19 Disease.

Authors:  Jeffrey Petersen; Darshana Jhala
Journal:  Clin Pathol       Date:  2022-01-07

5.  A cross-sectional study of COVID-19-related knowledge, risk perceptions, and preventive practices among pharmacy students in Bangladesh.

Authors:  Sadia Afruz Ether; Faisal Abdullah Emon; Asm Roknuzzaman; Md Rakibuzzaman; Fahad Imtiaz Rahman; Md Rabiul Islam
Journal:  SAGE Open Med       Date:  2022-01-18

6.  The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study.

Authors:  Md Rabiul Islam; Moynul Hasan; Waheeda Nasreen; Md Ismail Tushar; Mohiuddin Ahmed Bhuiyan
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

7.  Predictors of Severity and Mortality in Chronic Liver Disease Patients With COVID-19 During the Second Wave of the Pandemic in India.

Authors:  Pankaj Nawghare; Shubham Jain; Sanjay Chandnani; Saurabh Bansal; Sameet Patel; Partha Debnath; Siddhesh Rane; Rahul Deshmukh; Pravin Rathi; Qais Contractor
Journal:  Cureus       Date:  2022-01-03

8.  Upsurge of Dengue Prevalence During the Third Wave of COVID-19 Pandemic in Bangladesh: Pouring Gasoline to Fire.

Authors:  Fahad Imtiaz Rahman; Sadia Afruz Ether; Md Rabiul Islam
Journal:  Clin Pathol       Date:  2022-02-03

9.  The status and analysis of common mutations found in the SARS-CoV-2 whole genome sequences from Bangladesh.

Authors:  Sadniman Rahman; Md Asaduzzaman Shishir; Md Ismail Hosen; Miftahul Jannat Khan; Ashiqul Arefin; Ashfaqul Muid Khandaker
Journal:  Gene Rep       Date:  2022-04-04

10.  New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge.

Authors:  Salsabil Islam; Towhidul Islam; Md Rabiul Islam
Journal:  Clin Pathol       Date:  2022-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.